Topical Application of Latanoprost in Diabetic Retinopathy
Diabetic RetinopathyRandomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.
Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.
Proliferative Diabetic RetinopathyThe used of reduced fluence parameters for panretinal photocoagulation decreases pain as perceived by the patient, compared to traditional parameters.
Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation
Proliferative Diabetic RetinopathyThe study wants to show if the medication etoricoxib 120 mg have reduces the patients pain during the laser photocoagulation, for diabetic retinopathy.
Diabetic Retinopathy Candesartan Trials
Type 1 DiabetesThe primary objective is to determine whether candesartan, compared to placebo reduces the incidence of diabetic retinopathy in normotensive, normoalbuminuric type 1 diabetic patients without retinopathy. The secondary objective is to determine whether candesartan, compared to placebo, beneficially influences the rate of change in urinary albumin excretion rate (UAER). This study is part of the DIRECT Programme also including secondary prevention studies of diabetic retinopathy in both type 1 and type 2 diabetes. The primary objective for all three pooled studies is to determine whether candesartan, compared to placebo, reduces the incidence of microalbuminuria in type 1 and type 2 diabetic patients.
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Diabetic RetinopathyThe most common ocular disease in patients with diabetes, diabetic retinopathy, is present in approximately 40% of diabetic patients; about 8% of diabetic patients have vision threatening diabetic retinopathy. Although intensive control of blood glucose has been shown to reduce the development and progression of diabetic retinopathy, intensive control of glucose is usually not achieved in clinical practice.
Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes
Proliferative Diabetic RetinopathyPremacular Subhyaloid hemorrhage is a sudden profound loss of vision in eyes with proliferative diabetic retinopathy (PDR). Pars plana vitrectomy is the treatment of choice for premacular hemorrhage in eyes with proliferative changes. Nd:YAG laser hyaloidotomy has been used to evacuate the premacular hemorrhage
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal...
Retinal DetachmentVitrectomy2 moreThe purpose of this study is to assess the retinal redetachment rates with 1000 centistoke versus 5000 centistoke silicone oil tamponade for repair of complex retinal detachments.
Nepafenac Once Daily for Macular Edema - Study 2
Non-Proliferative Diabetic RetinopathyCataractThe purpose of this study is to demonstrate superiority of Nepafenac Ophthalmic Suspension, 0.3% dosed once daily relative to Nepafenac Vehicle based upon clinical outcomes among diabetic participants following cataract surgery.
Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy
Diabetic RetinopathyRetinal DetachmentSubjects receiving 16% C3F8 gas tamponade during vitrectomy will have better visual acuity and similar postoperative complications to subjects who receive silicone oil tamponade during vitrectomy.
Retinal Ischemia Characterization in Diabetes - "RICHARD"
Diabetic RetinopathyRetinal ischemia characterization in diabetes - RICHARD